Device Industry Aims To Prevent Image Problems That Have Plagued Pharma
This article was originally published in The Gray Sheet
Recent polling data commissioned by AdvaMed suggest that medical devices, if not the industry itself, are still in relative good graces with the public, but that clear vulnerabilities exist
You may also be interested in...
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.
Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.
AdvaMed CEO Steve Ubl is leaving the device trade association to take the helm of the Pharmaceutical Research and Manufacturers of America. Ubl has led AdvaMed for 10 years, raising the profile of the device industry among policymakers, fighting perception battles and, of course, opposing the device tax.